• Media type: E-Article
  • Title: The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients : results of a Nationwide Observational Study (PROSa)
  • Contributor: Eichler, Martin [Author]; Singer, Susanne [Author]; Hentschel, Leopold [Author]; Richter, Stephan [Author]; Hohenberger, Peter [Author]; Kasper, Bernd [Author]; Andreou, Dimosthenis [Author]; Pink, Daniel [Author]; Jakob, Jens [Author]; Grützmann, Robert [Author]; Fung, Stephen [Author]; Wardelmann, Eva [Author]; Arndt, Karin [Author]; Heidt, Vitali [Author]; Zapata Bonilla, Sergio Armando [Author]; Gaidzik, Verena I. [Author]; Jambor, Helena K. [Author]; Weitz, Jürgen [Author]; Schaser, Klaus-Dieter [Author]; Bornhäuser, Martin [Author]; Schmitt, Jochen [Author]; Schuler, Markus K. [Author]
  • Published: [2024]
  • Published in: British Journal of Cancer ; 126 (2022), Seite 1346-1354
  • Language: English
  • DOI: 10.1038/s41416-022-01702-z
  • Keywords: Health-Related Quality of Life ; gesundheitsbezogene Lebensqualität ; cancer ; Sarcomas ; Krebs ; Sarkome
  • Origination:
  • Footnote:
  • Description: BACKGROUND: Sarcomas are rare cancers of high heterogeneity. Health-Related Quality of Life (HRQoL) has been shown to be a prognostic factor for survival in other cancer entities but it is unclear whether this applies to sarcoma patients. PATIENTS AND METHODS: HRQoL was prospectively assessed in adult sarcoma patients from 2017 to 2020 in 39 German recruiting sites using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQC30). Vital status was ascertained over the course of 1 year. HRQoL domains were analysed by multivariable cox-regressions including clinical and socio-economic risk factors. RESULTS: Of 1102 patients, 126 (11.4%) died during follow-up. The hazard ratio (HR) for global health was 0.73 per 10-point increase (95% confidence interval (CI) 0.64–0.85). HR for the HRQoL-summary score was 0.74 (CI 0.64–0.85) and for physical functioning 0.82 (CI 0.74–0.89). There was also evidence that fatigue (HR 1.17, CI 1.10–1.25), appetite loss (HR 1.15, CI 1.09–1.21) and pain (HR 1.14, CI 1.08–1.20) are prognostic factors for survival. CONCLUSION: Our study adds sarcoma-specific evidence to the existing data about cancer survival in general. Clinicians and caregivers should be aware of the relations between HRQoL and survival probability and include HRQoL in routine assessment.
  • Access State: Open Access
  • Rights information: Attribution (CC BY)